1,714
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Impact of postmenopausal vaginal discomfort on sex and relationships in Brazil: the CLOSER survey

ORCID Icon, ORCID Icon, ORCID Icon, , & ORCID Icon
Pages 593-599 | Received 04 Dec 2020, Accepted 20 Mar 2021, Published online: 26 Apr 2021

References

  • North American Menopause Society (NAMS). The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. 2020;27(9):976–992.
  • Pitkin J. BMS – consensus statement. Post Reprod Health. 2018;24(3):133–138.
  • Nappi RE, Martini E, Cucinella L, et al. Addressing vulvovaginal atrophy (VVA)/genitourinary syndrome of menopause (GSM) for healthy aging in women. Front Endocrinol (Lausanne)). 2019;10:561.
  • Nappi RE, Kokot-Kierepa M. Vaginal health: insights, views & attitudes (VIVA) – results from an international survey. Climacteric. 2012;15(1):36–44.
  • Nappi RE, Palacios S, Particco M, et al. The REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey in Europe: country-specific comparisons of postmenopausal women's perceptions, experiences and needs. Maturitas. 2016;91:81–90.
  • Panay N, Palacios S, Bruyniks N, et al. Symptom severity and quality of life in the management of vulvovaginal atrophy in postmenopausal women. Maturitas. 2019;124:55–61.
  • Nappi RE, Palacios S. Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause. Climacteric. 2014;17(1):3–9.
  • Nappi RE, de Melo NR, Martino M, et al. Vaginal health: insights, views & attitudes (VIVA-LATAM): results from a survey in Latin America. Climacteric. 2018;21(4):397–403.
  • Pompei LM, Wender MCO, de Melo NR, et al. Vaginal health: insights, views & attitudes survey in Latin America (VIVA-LATAM): focus on Brazil. Climacteric. 2021;24(2):157–163.
  • Domoney C, Currie H, Panay N, et al. The CLOSER survey: impact of postmenopausal vaginal discomfort on women and male partners in the UK. Menopause Int. 2013;19(2):69–76.
  • Guidozzi F, Thomas C, Smith T, et al. CLarifying vaginal atrophy's impact On SEx and Relationships (CLOSER) survey in South Africa. Climacteric. 2017;20(1):49–54.
  • Nappi RE, Kingsberg S, Maamari R, et al. The CLOSER (CLarifying Vaginal Atrophy's Impact On SEx and Relationships) survey: implications of vaginal discomfort in postmenopausal women and in male partners. J Sex Med. 2013;10(9):2232–2241.
  • Nappi RE, Mattsson L, Lachowsky M, et al. The CLOSER survey: impact of postmenopausal vaginal discomfort on relationships between women and their partners in Northern and Southern Europe. Maturitas. 2013;75(4):373–379.
  • Simon JA, Kokot-Kierepa M, Goldstein J, et al. Vaginal health in the United States: results from the vaginal health: insights, views & attitudes survey. Menopause. 2013;20(10):1043–1048.
  • Baber RJ, Panay N, Fenton A. 2016 IMS Recommendations on women's midlife health and menopause hormone therapy. Climacteric. 2016;19(2):109–150.
  • Palacios S, Nappi RE, Shapiro M, et al. An individualized approach to the management of vaginal atrophy in Latin America. Menopause. 2019;26(8):919–928.
  • Parish SJ, Faubion SS, Weinberg M, et al. The MATE survey: men's perceptions and attitudes towards menopause and their role in partners' menopausal transition. Menopause. 2019;26(10):1110–1116.
  • Jannini EA, Nappi RE. Couplepause: a new paradigm in treating sexual dysfunction during menopause and andropause. Sex Med Rev. 2018;6(3):384–395.
  • Pompei LM, Machado RB, Wender MCO, et al. Consenso Brasileiro de Terapêutica Hormonal da Menopausa [Portuguese] (Brazilian Consensus on Hormonal Therapies of the Menopause); 2018 [2020 Sep]. Available from: http://sobrac.org.br/consenso_brasileiro_de_th_da_menopausa_2018.html.
  • Rees M, Pérez-López FR, Ceasu I, EMAS, et al. EMAS clinical guide: low-dose vaginal estrogens for postmenopausal vaginal atrophy. Maturitas. 2012;73(2):171–174.
  • Derzko CM, Röhrich S, Panay N. Does age at the start of treatment for vaginal atrophy predict response to vaginal estrogen therapy? Post hoc analysis of data from a randomized clinical trial involving 205 women treated with 10 μg estradiol vaginal tablets. Menopause. 2020;28(2):113–118.
  • Palacios S, Henderson VW, Siseles N, et al. Age of menopause and impact of climacteric symptoms by geographical region. Climacteric. 2010;13(5):419–428.
  • Sturdee DW, Panay N. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric. 2010;13(6):509–522.
  • Roman Lay AA, do Nascimento CF, de Oliveira Duarte YA, et al. Age at natural menopause and mortality: a survival analysis of elderly residents of São Paulo. Brazil. Maturitas. 2018;117:29–33.
  • Castelo-Branco C, Cancelo MJ, Villero J, et al. Management of post-menopausal vaginal atrophy and atrophic vaginitis. Maturitas. 2005;52(Suppl 1):S46–S52.